Stryker Corporation

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:01 2024-05-10 pm EDT			5-day change	1st Jan Change
330.6 ^USD	-0.08%		+0.65%	+10.39%

May. 09	Stryker Keeps Quarterly Dividend at $0.80 a Share, Payable July 31 to Shareholders of Record on June 28	MT
May. 09	Stryker Corporation Declares Quarterly Dividend, Payable on July 31, 2024	CI

Stryker Corporation Provides Earnings Guidance for the Full Year of 2019

July 25, 2019 at 04:10 pm EDT

Stryker Corporation provided earnings guidance for the full year of 2019. Based on second quarter performance The company expects 2019 organic net sales growth to be in the range of 7.5% to 8.0%.

Latest news about Stryker Corporation

Stryker Keeps Quarterly Dividend at $0.80 a Share, Payable July 31 to Shareholders of Record on June 28	May. 09	MT
Stryker Corporation Declares Quarterly Dividend, Payable on July 31, 2024	May. 09	CI
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices	May. 02	RE
UBS Adjusts Stryker Price Target to $351 From $339, Maintains Neutral Rating	May. 01	MT
BTIG Adjusts Price Target on Stryker to $369 From $366	May. 01	MT
Piper Sandler Adjusts Price Target on Stryker to $380 From $375	May. 01	MT
Baird Adjusts Price Target on Stryker to $378 From $367	May. 01	MT
Stifel Adjusts Price Target on Stryker to $375 From $350	May. 01	MT
Oppenheimer Adjusts Price Target on Stryker to $360 From $350	May. 01	MT
Roth MKM Adjusts Price Target on Stryker to $405 From $348	May. 01	MT
Jefferies Adjusts Price Target on Stryker to $400 From $390, Keeps Buy Rating	May. 01	MT
Bernstein Adjusts Price Target on Stryker to $393 From $385, Keeps Outperform Rating	May. 01	MT
Nephron Research Raises Stryker's Price Target to $400 From $385	May. 01	MT
Barclays Raises Stryker's Price Target to $376 From $372	May. 01	MT
Wells Fargo Adjusts Price Target on Stryker to $381 From $364	May. 01	MT
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants	Apr. 30	RE
Stryker's Q1 Adjusted EPS, Sales Increase; 2024 EPS Guidance Boosted; Shares Drop After Hours	Apr. 30	MT
Stryker Guides For 2024 EPS of $11.85-$12.05 on Sales Growth of 8.5%-9.5%, vs CIQ Analyst Consensus of $11.85/Share on Sales of $22.1 Billion	Apr. 30	MT
Earnings Flash (SYK) STRYKER CORPORATION Reports Q1 Revenue $5.24B, vs. Street Est of $5.11B	Apr. 30	MT
Stryker Lifts Organic Sales Outlook After 1Q Rise	Apr. 30	DJ
Transcript : Stryker Corporation, Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Stryker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Stryker Corporation Provides Earnings Guidance for the Full Year 2024	Apr. 30	CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	Apr. 30
Stryker Corporation acquired Mfphd, LLC.	Apr. 29	CI

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-22 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Stryker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

330.6 USD

Average target price

372.4 USD

Spread / Average Target

+12.64%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+10.39%	126B
SMITH & NEPHEW PLC	-6.86%	10.96B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.52%	8.97B
GLAUKOS CORPORATION	+38.96%	5.56B
INSPIRE MEDICAL SYSTEMS, INC.	-17.50%	4.99B
AXONICS, INC.	+8.36%	3.44B
ENOVIS CORPORATION	-8.84%	2.8B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-7.52%	2.18B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-3.00%	2.16B
DOUBLE MEDICAL TECHNOLOGY INC.	-21.88%	1.82B

Medical Devices & Implants